Abstract
A series of 4,5-disubstituted-1,2,4-triazole-3-thione derivatives (4a-e) and their N-Mannich bases (5a-e), together with a S-benzyl derivative (6), were synthesized and evaluated as antimycobacterial and antiproliferative agents. The structures of the compounds were established by IR, 1H-NMR, 13C-NMR and 2D-NMR spectroscopic methods and microanalysis. 4 and 5 were screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv (ATCC 27294). Three of the tested compounds (4d, 4e and 5e) were found to be active in the primary screen. Among them, compound 4e was the most potent one with IC90 and IC50 values of 27.5 and 20.8 µg/mL, respectively. Additionally, compounds 4b, 4c, 5b, 5c, 5e and 6 were subjected to the NCI’s in vitro disease-oriented antitumor screening to be evaluated for antitumor activity at a single dose of 10 µM. The S-benzyl derivative 6 exhibited promising antiproliferative activity against leukemia CCRF-CEM, RPMI-8226 and SR, non-small cell lung cancer HOP-92, melanoma UACC-62 and renal cancer UO-31 cell lines.
Keywords: Antimycobacterial activity, Antitumor activity, Mannich bases, 1, 2, 4-Triazole-3-thiones.
Letters in Drug Design & Discovery
Title:Synthesis, Characterization, Antimycobacterial and Anticancer Evaluation of New 1,2,4-Triazole Derivatives
Volume: 11 Issue: 3
Author(s): G. Cihan-Ustundag, B. Simsek, E. Ilhan and G. Capan
Affiliation:
Keywords: Antimycobacterial activity, Antitumor activity, Mannich bases, 1, 2, 4-Triazole-3-thiones.
Abstract: A series of 4,5-disubstituted-1,2,4-triazole-3-thione derivatives (4a-e) and their N-Mannich bases (5a-e), together with a S-benzyl derivative (6), were synthesized and evaluated as antimycobacterial and antiproliferative agents. The structures of the compounds were established by IR, 1H-NMR, 13C-NMR and 2D-NMR spectroscopic methods and microanalysis. 4 and 5 were screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv (ATCC 27294). Three of the tested compounds (4d, 4e and 5e) were found to be active in the primary screen. Among them, compound 4e was the most potent one with IC90 and IC50 values of 27.5 and 20.8 µg/mL, respectively. Additionally, compounds 4b, 4c, 5b, 5c, 5e and 6 were subjected to the NCI’s in vitro disease-oriented antitumor screening to be evaluated for antitumor activity at a single dose of 10 µM. The S-benzyl derivative 6 exhibited promising antiproliferative activity against leukemia CCRF-CEM, RPMI-8226 and SR, non-small cell lung cancer HOP-92, melanoma UACC-62 and renal cancer UO-31 cell lines.
Export Options
About this article
Cite this article as:
Cihan-Ustundag G., Simsek B., Ilhan E. and Capan G., Synthesis, Characterization, Antimycobacterial and Anticancer Evaluation of New 1,2,4-Triazole Derivatives, Letters in Drug Design & Discovery 2014; 11 (3) . https://dx.doi.org/10.2174/157018081131000074
DOI https://dx.doi.org/10.2174/157018081131000074 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From Target Therapy to miRNA Therapeutics of Human Multiple Myeloma: Theoretical and Technological Issues in the Evolving Scenario
Current Drug Targets Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Current Medicinal Chemistry - Anti-Cancer Agents Antioxidants in Health, Disease and Aging
CNS & Neurological Disorders - Drug Targets Apoptosis: Potential Therapeutic Targets for New Drug Discovery
Current Medicinal Chemistry Involvement of Cannabinoids in Cellular Proliferation
Mini-Reviews in Medicinal Chemistry The Delivery of Biologically Active (Therapeutic) Peptides and Proteins into Cells
Current Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases
Anti-Infective Agents in Medicinal Chemistry Plant Derived Inhibitor Sulforaphane in Combinatorial Therapy Against Therapeutically Challenging Pancreatic Cancer
Anti-Cancer Agents in Medicinal Chemistry mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy
Current Drug Metabolism The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs
Clinical Cancer Drugs New Targets of Therapy in T-Cell Lymphomas
Current Drug Targets Recent Innovations in Antibody-Mediated, Targeted Particulate Nanotechnology and Implications for Advanced Visualisation and Drug Delivery
Current Nanoscience Analytical Methods for Metallothionein Detection
Current Analytical Chemistry New Functions of the Inositol Polyphosphate 5-Phosphatases in Cancer
Current Pharmaceutical Design Induction and Escalation Therapies in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cancer Cell Cannibalism: A Primeval Option to Survive.
Current Molecular Medicine Cancer Chemoprevention with Green Tea Catechins: From Bench to Bed
Current Drug Targets Synthesis and Biological Evaluation of 2-, 3-, and 4-Acylaminocinnamyl-Nhydroxyamides as Novel Synthetic HDAC Inhibitors
Medicinal Chemistry